Thromboxane A2 is a potent eicosanoid derived from arachidonic acid, primarily produced by activated platelets, and plays a crucial role in platelet aggregation and vasoconstriction. It is a key mediator in hemostasis and thrombosis, making it a target for antiplatelet therapies such as aspirin.